We examined midbrain, medial temporal lobe, and basal ganglia serotonin transporter (SERT) distribution volume ratio (DVR) values in subjects with major depressive disorder versus healthy volunteers using a selective SERT radioligand and single photon emission computed tomography (SPECT). We hypothesized that the DVR value for SERT binding would be lower in depressed versus non-depressed subjects. There was significant probability that lower DVR values could distinguish between depressed and nondepressed subjects in the midbrain, medial temporal lobe, and the right and left basal ganglia. These findings confirm prior observations of lower SERT binding in depression, and suggest that low SERT binding may represent a putative biomarker of depression. Future studies are needed to confirm these observations.
Introduction
Studies suggest that serotonin transporter (SERT) activity may reflect the general state of neuronal serotonin (5-HT) activity throughout the brain. For example, SERT sites in humans are primarily located in the thalamus, hypothalamus, amygdala, ventral striatum, nucleus accumbens, cingulate gyrus, and occipital lobes (Kovachich et al., 1992; Gurevich and Joyce, 1996) , regions that are involved in the genesis and modulation of mood, affect, rage, and euphoria. Serotonin may therefore play a role in the pathophysiology of depression and may also facilitate the therapeutic action of some antidepressant drugs. For example, several postmortem studies reported lower SERT density in brain samples of depressed patients compared to non-depressed individuals (Leake et al., 1991; Arango et al., 1995) . Arango et al. (1995) found lower SERT density in 42 of 43 brain regions in depressed compared to non-depressed individuals, with the lowest SERT density in the ventrolateral prefrontal cortex -a region involved in mediating behavior and emotions (Bennett and Hacker, 2005) , and a region showing low glucose metabolism in depression (Ito et al., 1996; Oda et al., 2003) . Joensuu et al. (2007) also reported decreased midbrain SERT binding in 29 depressed patients compared to 19 healthy controls. However, decreased SERT density in depression has not been universally observed (Conway and Brunswick, 1985; Lawrence et al., 1997) .
Imaging studies of pre-and post-synaptic 5-HT receptors have also shown decreased 5-HT 2 (Meyer et al., 1999; Yatham et al., 1999) and 5-HT 2A receptor binding (Biver et al., 1997; Massou et al., 1997) in depressed patients compared to non-depressed subjects, although these findings are not universally observed (D'haenen et al., 1992) . While studies of SERT binding in depression have been attempted using 11 C and 18 F-labeled fluoxetine, sertraline, citalopram and paroxetine (Dannals et al., 1990; Suehiro et al., 1991; Das and Mukherjee, 1993) , these agents were not suitable for imaging in humans (Scheffel et al., 1994) . In contrast, the selective radioligand, [ 11 C](+)McN5652, has been used successfully to image SERT sites in humans (Suehiro et al., 1993; Szabo et al., 1995) . Although one preliminary positron emission tomography (PET) study showed significantly greater 
